News & Media

News & Media

June 11, 2024

UMass Chan Receives $2.2 Million to Fund Gene Therapy for Cockayne Syndrome

UMass Chan Medical School has received $2.2 million from a nonprofit patient-advocacy organization to contract with Andelyn Biosciences to manufacture clinical grade AAV9-CSA vector to treat Cockayne syndrome.

News & Media

February 23, 2024

Andelyn Biosciences Announces New Chief Operations Officer

(COLUMBUS, Ohio) – Andelyn Biosciences announces the promotion and appointment of Cyrill Kellerhals as Chief Operations Officer (COO). Cyrill will lead...

Play video
News & Media

June 22, 2023

Cell and Gene Therapy CDMO Andelyn Biosciences Celebrates Over 20 Years of Leadership and Innovation with Opening of New 180,000 Square Foot Manufacturing Headquarters

Columbus, Ohio – June 22, 2023 – Andelyn Biosciences, a pioneer in the development and manufacturing of cell and gene...

News & Media

March 27, 2023

Andelyn Biosciences Announce New Chief Commercial Officer

(COLUMBUS, Ohio) – Andelyn Biosciences announces the appointment of Matt Niloff as Chief Commercial Officer (CCO). Niloff will lead the...

News & Media

March 8, 2023

Inspiring the Next Generation of Women in Life Sciences

In honor of International Women's Day, EPM brings you an exclusive roundup of inspiring commentary from over 25 empowering women in the STEM and life sciences industries. These women share their personal experiences of working in these fields, the challenges they face, and their tips for encouraging young women who are wishing to pursue a career in STEM.

News & Media

March 1, 2023

Andelyn Biosciences Board of Directors Announce New CEO

(COLUMBUS, Ohio) – Andelyn Biosciences Chief Operations Officer Wade Macedone has been promoted to CEO of the gene and cell...

News & Media

February 1, 2023

Andelyn Biosciences and Odylia Therapeutics Partner to Manufacture Novel Gene Therapy for Vision Loss

Novel AAV Capsid Anc80 enables efficient gene transfer COLUMBUS, OH, 31st JANUARY, 2023 – Andelyn Biosciences, Inc., a pioneering and...

News & Media

July 11, 2022

Optimizing Process Development Early – A critical factor in successful viral vector scale up and large scale manufacture

John Ketz and Denis Kole speak with Brandy Sargent on The Cell Culture Dish podcast about viral vector production, including current manufacturing challenges, navigating the road to commercialization, and successful scale up strategies.

News & Media

February 14, 2022

Reliability and the Future of Cell & Gene Therapies

Mayo Pujols, CEO of Andelyn Biosciences, discusses how Cell & Gene companies are focusing on reliability and predictability to further advance this innovative therapy.

News & Media

January 13, 2022

FDA Accepts GMP Plasmid DMF and Capacity Expansion Enabling Andelyn Biosciences to Offer Faster Gene Therapy Development

COLUMBUS, OH, January 13, 2022 – Andelyn Biosciences, a pioneering cell and gene therapy CDMO born out of Nationwide Children’s Hospital, today...

Connect Here With Our Business Team